Dr. Fleshner's clinical practice is in urologic oncology with research interests in prostate and bladder cancer.
Neil E Fleshner
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
J Clin Oncol. 2017 Apr 14;:JCO2016692327
J Natl Cancer Inst. 2017 Apr 01;109(4):
World J Urol. 2017 Feb 15;:
Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
Transl Oncol. 2017 Feb 03;10(2):168-177
Variant Histology and Clinicopathologic Features of Prostate Cancer in Men Aged <50 Years Treated with Radical Prostatectomy.
J Urol. 2017 Jan 24;:
The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy.
Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E424-E427
Nature. 2017 Jan 09;:
Urol Oncol. 2017 Jan 03;:
Development and External Validation of a Biopsy-Derived Nomogram to Predict Risk of Ipsilateral Extraprostatic Extension.
BJU Int. 2016 Dec 08;:
Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking.
Nat Nanotechnol. 2016 Nov 21;:
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Martin Barkin Chair, Division of Urology, Department of Surgery, University of Toronto
Professor, Department of Surgery, University of Toronto